ArticleCommunications biology2025
Inhibition of inner ear macrophage phagocytosis alleviates cisplatin-induced ototoxicity.
Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cancer therapy-induced ototoxicity: Current challenges and emerging management strategies.Animal models and experimental medicine · 2026Review
- Sentinels or saboteurs, the Janus face of cochlear-resident macrophages in hearing loss: spatiotemporal distribution, pathophysiological functions, and translational potential.Journal of neuroinflammation · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The immune response is considered a significant pathological mechanism of inner ear damage. However, the role of macrophages, as key components of immune cells, in immunity in the inner ear remains elusive. Evidence from other organs indicates that phagocytosis, a core function of macrophages, plays a crucial role in maintaining homeostasis, development, and tissue repair regeneration. However, it has rarely been studied in the inner ear. This field may currently hold new insights. In this study, we aimed to investigate the immunological contribution of resident macrophages in the inner ear to cisplatin-induced ototoxicity. By using clodronate liposomes and cytochalasin to deplete macrophages or inhibit macrophage phagocytosis locally, we first elucidated the dynamic changes in the immune state of inner ear macrophages during cisplatin injury through multimodal and multidimensional approaches. High-spatiotemporal-resolution single-cell analysis and real-time imaging of macrophages during zebrafish hair cell death identified proinflammatory subsets during cisplatin injury. We found that macrophage activation through phagocytosis synergized with the inflammatory response and that inhibiting macrophage phagocytosis could ameliorate cisplatin-induced ototoxicity. Finally, we discuss how the highly plastic phagocytic function of resident macrophages in the inner ear holds potential for the development of strategies for treating cisplatin-induced hearing loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.